Carestream DRX-LC Detector Makes Long-Length Imaging Easier And More Precise

Carestream Health’s new, versatile DRX-LC Detector is designed to improve patient comfort, image quality and diagnostic confidence, and productivity for long-length image capture in orthopaedics.

DRX-LC Detector

Capturing long-length images is tedious and time-consuming, especially for pediatric patients and those with limited mobility. The traditional multi-shot approach requires three to five exposures followed by manipulation and stitching of the images. Carestream’s DRX-LC Detector captures long-bone and spine images with a single exposure, making long-length imaging easier and more comfortable for both patient and radiographer by reducing hold time and the need for retakes. The single-shot exposure also delivers improved image quality—no more stitching—and reduces patient dose.

“Our smart, versatile DRX-LC delivers three powerful outcomes,” said Marco Riolfo, Worldwide Marketing Manager, Global X-ray Solutions, at Carestream. “It improves patient comfort and care by reducing the hold time and the likelihood of retakes (lowering dose). It helps improve diagnostic confidence and treatment planning by delivering improved image quality and precision; and it increases productivity and makes the image capture experience easier on radiographers.”

The second-generation long-length detector has several new features. The first is compatibility with digital radiography (DR) mobile systems and mobile retrofits, in addition to X-ray rooms and room retrofits. The mobility of the system lets facilities use the same detector for all phases of surgical treatment from pre-planning imaging in the radiology department to capturing images during the procedure in the OR to confirm placement and for post-operative assessment.

The versatile detector can be wireless or tethered. The wireless option eliminates trip hazards in the OR and minimizes the risk of contamination. The DRX-LC Detector has a Cesium (CsI) scintillator for better dose efficiency.

“The new wireless design, expanded system compatibility and mobile capacity of the DRX-LC Detector lets facilities expand their use of the system, maximizing their investment and bringing the benefits to more users,” said Mr. Riolfo. “Its versatility makes it a practical solution for facilities that conduct several long-length exams to sites that see a high volume of patients.”

The DRX-LC Detector uses ImageView Software, powered by Eclipse, the engine behind the company’s cutting-edge software platform that uses proprietary algorithms and artificial intelligence to amplify the value of the entire imaging chain. Like other Carestream solutions, it features X-Factor, which allows the detector to be shared across all DRX equipment.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version